Pioglitazone improves whole‐body aerobic capacity and skeletal muscle energy metabolism in patients with metabolic syndrome

AIMS/INTRODUCTION: Low aerobic capacity is a strong and independent predictor of all‐cause mortality in patients with metabolic syndrome (MetS). Here, we investigated the effects of pioglitazone treatment on whole‐body aerobic capacity and skeletal muscle energy metabolism in MetS patients. MATERIAL...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Diabetes Investig
Главные авторы: Yokota, Takashi, Kinugawa, Shintaro, Hirabayashi, Kagami, Suga, Tadashi, Takada, Shingo, Omokawa, Masashi, Kadoguchi, Tomoyasu, Takahashi, Masashige, Fukushima, Arata, Matsushima, Shouji, Yamato, Mayumi, Okita, Koichi, Tsutsui, Hiroyuki
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2017
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497029/
https://ncbi.nlm.nih.gov/pubmed/27930876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12606
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы